190 related articles for article (PubMed ID: 28833832)
1. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.
McDonell MG; Leickly E; McPherson S; Skalisky J; Hirchak K; Oluwoye O; Srebnik D; Roll JM; Ries RK
Am J Addict; 2017 Oct; 26(7):673-675. PubMed ID: 28833832
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.
McDonell MG; Leickly E; McPherson S; Skalisky J; Srebnik D; Angelo F; Vilardaga R; Nepom JR; Roll JM; Ries RK
Am J Psychiatry; 2017 Apr; 174(4):370-377. PubMed ID: 28135843
[TBL] [Abstract][Full Text] [Related]
3. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.
McDonell MG; Skalisky J; Leickly E; McPherson S; Battalio S; Nepom JR; Srebnik D; Roll J; Ries RK
Drug Alcohol Depend; 2015 Dec; 157():184-7. PubMed ID: 26475403
[TBL] [Abstract][Full Text] [Related]
4. High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.
Leickly E; McDonell MG; Vilardaga R; Angelo FA; Lowe JM; McPherson S; Srebnik D; Roll JM; Ries RK
Am J Drug Alcohol Abuse; 2015 May; 41(3):246-50. PubMed ID: 25695340
[TBL] [Abstract][Full Text] [Related]
5. Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.
Lowe JM; McDonell MG; Leickly E; Angelo FA; Vilardaga R; McPherson S; Srebnik D; Roll J; Ries RK
Alcohol Clin Exp Res; 2015 May; 39(5):905-10. PubMed ID: 25866234
[TBL] [Abstract][Full Text] [Related]
6. Urine Ethyl Glucuronide Unraveling the Reality of Abstinence Monitoring in a Routine Outpatient Setting: A Cross-Sectional Comparison with Ethanol, Self Report and Clinical Judgment.
Barrio P; Teixidor L; Rico N; Bruguera P; Ortega L; Bedini JL; Gual A
Eur Addict Res; 2016; 22(5):243-8. PubMed ID: 27220985
[TBL] [Abstract][Full Text] [Related]
7. Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness.
Leickly E; Skalisky J; Oluwoye O; McPherson SM; Srebnik D; Roll JM; Ries RK; McDonell MG
Subst Abus; 2018; 39(3):271-274. PubMed ID: 29161228
[TBL] [Abstract][Full Text] [Related]
8. Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.
McDonell MG; Skalisky J; Leickly E; Orr MF; McPherson S; Roll J; Hill-Kapturczak N; Javors M
Psychol Addict Behav; 2017 Aug; 31(5):608-613. PubMed ID: 28714726
[TBL] [Abstract][Full Text] [Related]
9. Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.
Barrio P; Teixidor L; Ortega L; Lligoña A; Rico N; Bedini JL; Vieta E; Gual A
Drug Alcohol Depend; 2018 Feb; 183():225-230. PubMed ID: 29291550
[TBL] [Abstract][Full Text] [Related]
10. Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.
Oluwoye O; Skalisky J; Burduli E; Chaytor NS; McPherson S; Murphy SM; Herron J; Hirchak K; Burley M; Ries RK; Roll JM; McDonell MG
Contemp Clin Trials; 2018 Jun; 69():92-98. PubMed ID: 29680318
[TBL] [Abstract][Full Text] [Related]
11. Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.
McDonell MG; Howell DN; McPherson S; Cameron JM; Srebnik D; Roll JM; Ries RK
J Appl Behav Anal; 2012; 45(1):161-5. PubMed ID: 22403460
[TBL] [Abstract][Full Text] [Related]
12. Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment.
Albermann ME; Musshoff F; Doberentz E; Heese P; Banger M; Madea B
Int J Legal Med; 2012 Sep; 126(5):757-64. PubMed ID: 22752748
[TBL] [Abstract][Full Text] [Related]
13. Serious Mental Illness in Heavy Drinkers Is Associated with Poor Treatment Outcomes in Outpatients with Co-occurring Disorders.
Oluwoye O; Leickly E; Skalisky J; McPherson S; Hirchak K; Srebnik D; Roll JM; Ries RK; McDonell MG
Int J Ment Health Addict; 2018 Jun; 16(3):672-679. PubMed ID: 29973859
[TBL] [Abstract][Full Text] [Related]
14. Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.
Jatlow PI; Agro A; Wu R; Nadim H; Toll BA; Ralevski E; Nogueira C; Shi J; Dziura JD; Petrakis IL; O'Malley SS
Alcohol Clin Exp Res; 2014 Jul; 38(7):2056-65. PubMed ID: 24773137
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers.
Kharbouche H; Faouzi M; Sanchez N; Daeppen JB; Augsburger M; Mangin P; Staub C; Sporkert F
Int J Legal Med; 2012 Mar; 126(2):243-50. PubMed ID: 21910015
[TBL] [Abstract][Full Text] [Related]
16. Effect of Incentives for Alcohol Abstinence in Partnership With 3 American Indian and Alaska Native Communities: A Randomized Clinical Trial.
McDonell MG; Hirchak KA; Herron J; Lyons AJ; Alcover KC; Shaw J; Kordas G; Dirks LG; Jansen K; Avey J; Lillie K; Donovan D; McPherson SM; Dillard D; Ries R; Roll J; Buchwald D;
JAMA Psychiatry; 2021 Jun; 78(6):599-606. PubMed ID: 33656561
[TBL] [Abstract][Full Text] [Related]
17. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
Dahl H; Hammarberg A; Franck J; Helander A
Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
[TBL] [Abstract][Full Text] [Related]
18. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence.
Dahl H; Voltaire Carlsson A; Hillgren K; Helander A
Alcohol Alcohol; 2011; 46(3):278-82. PubMed ID: 21339184
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on a contingency management intervention for alcohol use among consumers with serious mental illness.
Leickly E; Skalisky J; Angelo FA; Srebnik D; McPherson S; Roll JM; Ries RK; McDonell MG
Psychiatr Rehabil J; 2019 Mar; 42(1):26-31. PubMed ID: 30475006
[TBL] [Abstract][Full Text] [Related]
20. Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy?
Pragst F; Yegles M
Ther Drug Monit; 2008 Apr; 30(2):255-63. PubMed ID: 18367991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
